Background
Dr. Oshima is a hepatobiliary and gastrointestinal pathologist and the director of the Johns Hopkins Liver Pathology Service.
Masks are required inside all of our care facilities. We are vaccinating all eligible patients. Learn more:
Vaccines, Boosters & Additional Doses | Testing | Patient Care | Visitor Guidelines | Coronavirus | Email Alerts
Find more COVID-19 testing locations on Maryland.gov.
Kiyoko Oshima, M.D., Ph.D.
Languages: English, Japanese
Pathology
Hepatobiliary; Pathology
Dr. Oshima is a hepatobiliary and gastrointestinal pathologist and the director of the Johns Hopkins Liver Pathology Service.
Her research focuses on the study of neoplastic and non-neoplastic processes of the hepatobiliary system. Her ongoing projects include:
Yoshizawa T, Hong SM, Jung D, Noe M, Keimen A, Wu P, Wirtz D, Hruban R, Wood L, Oshima K. Three dimensional analysis of extrahepatic cholangiocarcinoma and tumor budding. J Pathol. 2020 Aug; 251(4):400-410
Rowan DJ, Logunova V, Oshima K. Measured residual tumor cellularity correlates with survival in neoadjuvant treated pancreatic ductal adenocarcinomas. Ann Diagn Pathol. 2019 Feb; 38:93-98
Eskandari F, Rowan DJ, Hari P, Kapke J, Schneidewend R, E Hagen C, Oshima K. Liver biopsy findings in patients with hematopoietic cell transplantation. Hum Pathol. 2017 Aug; 66:136-143
Pant M, Oshima K. Cholesteryl Ester Storage Disease: An underdiagnosed cause of cirrhosis in adults. Ann Diagn Pathol. 2017 Dec; 31:66-70
Membership committee
Educational Travel and Awards Committee